The sanitation programs were not adequately designed to identify and/or reduce the risks of contamination.
Inspection Record
Agrisan Specialty Chemical & Pharmaceutical a division of Agrisan Inc. — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
The training of personnel in good manufacturing practices and/or the maintenance of records was inadequate.
The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.
The qualification and/or verification of utilities and/or support systems was inadequate.
The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.
Materials, bulk containers, major items of equipment, and/or the rooms were not properly identified.
Evaluation of production processes, equipment, and/or materials was inadequate.
The protection of products and/or materials from contamination was inadequate.
The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.
The identification, quarantine, and/or disposal of rejected materials was inadequate.
The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.
About this record
Extracted automatically from the document of the Health Canada inspection on 2022-02-23. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
